Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02696850 · ClinicalTrials.gov registry record · Phase 4
The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT02696850 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 80 participants.
The verdict
NCT02696850, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
The goal of this research project is to explore the impact of the addition of budesonide to high-volume, low-pressure nasal sinus saline irrigation (aka "Neti-Pot"-type systems) for patients with chronic rhinosinusitis with or without nasal polyps.
Interventions
- DRUG Budesonide
- DRUG Saline alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2017-04-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02696850
The ClinicalTrials.gov registry entry for NCT02696850 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Budesonide is the first listed.
NCT02696850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02696850 about?
NCT02696850 is a clinical study titled "The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis". The goal of this research project is to explore the impact of the addition of budesonide to high-volume, low-pressure nasal sinus saline irrigation (aka "Neti-Pot"-type systems) for patients with chronic rhinosinusitis with or without nasal polyps.
What is the current status of trial NCT02696850?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2016-01-01. Estimated completion is 2017-04-13.
What interventions are being tested in trial NCT02696850?
The interventions under investigation include: Budesonide (DRUG), Saline alone (DRUG).
Who is sponsoring clinical trial NCT02696850?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.